A Multiple Dose Pharmacokinetic/Pharmacodynamic and Safety and Tolerability Study of BMS-963272 in Obese But Otherwise Healthy Adults
Latest Information Update: 16 Apr 2020
Price :
$35 *
At a glance
- Drugs BMS 963272 (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 13 Apr 2020 Status changed from recruiting to completed.
- 10 Oct 2019 Status changed from not yet recruiting to recruiting.
- 07 Oct 2019 New trial record